Ten-year experience with CMF-based adjuvant chemotherapy in resectable breast cancer
- 1 June 1985
- journal article
- research article
- Published by Springer Science and Business Media LLC in Breast Cancer Research and Treatment
- Vol. 5 (2), 95-115
- https://doi.org/10.1007/bf01805984
Abstract
No abstract availableKeywords
This publication has 34 references indexed in Scilit:
- Progesterone Receptors as a Prognostic Factor in Stage II Breast CancerThe New England Journal of Medicine, 1983
- Multimodal treatment in operable breast cancer: five-year results of the CMF programme.BMJ, 1981
- Dose-Response Effect of Adjuvant Chemotherapy in Breast CancerThe New England Journal of Medicine, 1981
- Effects of cancer chemotherapy on gonadal function of patientsCancer Treatment Reviews, 1980
- TRIALS OF ADJUVANT CHEMOTHERAPY IN BREAST CANCERThe Lancet, 1979
- Surgical adjuvant chemotherapy.Results with one short course with cyclophosphamide after mastectomy for breast cancerCancer, 1978
- OVARIAN FUNCTION IN PATIENTS RECEIVING ADJUVANT CHEMOTHERAPY FOR BREAST CANCERThe Lancet, 1977
- Rationale for adjuvant chemotherapyCancer, 1977
- Response and survival in advanced breast cancer after two non-cross-resistant combinations.BMJ, 1976
- Surgical Adjuvant Chemotherapy in Cancer of the BreastAnnals of Surgery, 1968